BAJAJ BROKING

Notification close image
No new Notification messages
card image
Travel Food Services IPO is Open!
Apply for the Travel Food Services IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

6863

539872

BAJAJHCARE

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

BAJAJ HEALTHCARE LIMITED performance

Today’s low

Today’s high

₹ 468.40 ₹ 488.00
₹ 483.30

52 week low

52 week high

₹ 330.90 ₹ 745.00
₹ 483.30

Open Price

₹ 469.10

Prev. Close

₹ 466.60

Volume (Shares)

122766.00

Total traded value

₹ 593.32

Upper Circuit

₹ 559.90

Lower Circuit

₹ 373.30

info

BAJAJ HEALTHCARE LIMITED Share Price Update

As of the latest trading session, BAJAJ HEALTHCARE LIMITED share price is currently at ₹ 480.05, which is up by ₹ 13.44 from its previous closing. Today, the stock has fluctuated between ₹ 468.40 and ₹ 488.00. Over the past year, BAJAJ HEALTHCARE LIMITED has achieved a return of 24.79 %. In the last month alone, the return has been -12.22 %. Read More...

Investment Returns

Over 1 Month -12.22% Over 3 Months -19.72% Over 6 Months -19.09% Over 1 Year 24.79%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

BAJAJ HEALTHCARE LIMITED fundamentals


  • Market cap (Cr)

    1,530.50

  • P/E Ratio (TTM)

    37.34

  • Beta

    1.34

  • Book Value / share

    147.59

  • Return on equity

    -12.23%

  • EPS (TTM)

    13.59

  • Dividend yield

    0.21%

  • Net profit/quarter (Cr)

    11.18

info icon alternate text
  • Market cap (Cr)

    1,527.10

  • P/E Ratio (TTM)

    37.34

  • Beta

    1.27

  • Book Value / share

    147.59

  • Return on equity

    -12.23%

  • EPS (TTM)

    13.59

  • Dividend yield

    0.21%

  • Net profit/quarter (Cr)

    11.18

info icon alternate text

BAJAJ HEALTHCARE LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 154.47
Operating Expense 156.33
Net Profit 11.18
Net Profit Margin (%) 7.23
Earnings Per Share (EPS) 3.54
EBITDA 25.33
Effective Tax Rate (%) 1.10
Particulars DEC 2024 (Values in Cr)
Revenue 122.79
Operating Expense 113.51
Net Profit 11.72
Net Profit Margin (%) 9.54
Earnings Per Share (EPS) 3.65
EBITDA 24.00
Effective Tax Rate (%) -28.41
Particulars SEP 2024 (Values in Cr)
Revenue 133.09
Operating Expense 123.25
Net Profit 9.46
Net Profit Margin (%) 7.10
Earnings Per Share (EPS) 3.36
EBITDA 27.13
Effective Tax Rate (%) 32.93
Particulars JUN 2024 (Values in Cr)
Revenue 132.25
Operating Expense 122.91
Net Profit 7.13
Net Profit Margin (%) 5.39
Earnings Per Share (EPS) 2.59
EBITDA 25.34
Effective Tax Rate (%) 21.21
Particulars MAR 2024 (Values in Cr)
Revenue 133.90
Operating Expense 131.17
Net Profit -29.92
Net Profit Margin (%) -22.34
Earnings Per Share (EPS) -10.84
EBITDA -21.84
Effective Tax Rate (%) 8.96
Particulars MAR 2025 (Values in Cr)
Revenue 542.60
Operating Expense 515.99
Net Profit 39.50
Net Profit Margin (%) 7.27
Earnings Per Share (EPS) 13.29
EBITDA 101.83
Effective Tax Rate (%) 6.69
Particulars MAR 2024 (Values in Cr)
Revenue 473.42
Operating Expense 454.45
Net Profit -83.79
Net Profit Margin (%) -17.69
Earnings Per Share (EPS) -30.36
EBITDA 40.62
Effective Tax Rate (%) 14.08
Particulars MAR 2023 (Values in Cr)
Revenue 645.80
Operating Expense 569.19
Net Profit 43.02
Net Profit Margin (%) 6.66
Earnings Per Share (EPS) 15.59
EBITDA 112.95
Effective Tax Rate (%) 18.73
Particulars MAR 2022 (Values in Cr)
Revenue 679.89
Operating Expense 591.65
Net Profit 71.39
Net Profit Margin (%) 10.50
Earnings Per Share (EPS) 25.87
EBITDA 119.94
Effective Tax Rate (%) 20.40
Particulars MAR 2021 (Values in Cr)
Revenue 656.98
Operating Expense 545.07
Net Profit 83.11
Net Profit Margin (%) 12.65
Earnings Per Share (EPS) 30.11
EBITDA 143.23
Effective Tax Rate (%) 30.05
Particulars MAR 2024 (Values in Cr)
Book Value / Share 100.86
ROE % -12.23
ROCE % 7.96
Total Debt to Total Equity 1.16
EBITDA Margin 17.95
Particulars MAR 2023 (Values in Cr)
Book Value / Share 133.23
ROE % 12.36
ROCE % 13.97
Total Debt to Total Equity 0.97
EBITDA Margin 17.51
Particulars MAR 2022 (Values in Cr)
Book Value / Share 119.02
ROE % 24.33
ROCE % 19.90
Total Debt to Total Equity 0.75
EBITDA Margin 17.66
Particulars MAR 2021 (Values in Cr)
Book Value / Share 187.26
ROE % 38.09
ROCE % 35.67
Total Debt to Total Equity 0.62
EBITDA Margin 21.81
Particulars MAR 2020 (Values in Cr)
Book Value / Share 128.94
ROE % 18.92
ROCE % 19.32
Total Debt to Total Equity 0.64
EBITDA Margin 13.37
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.92
Total Assets 765.12
Total Liabilities 765.12
Total Equity 278.36
Share Outstanding 27598400
Price to Book Ratio 2.90
Return on Assets (%) -10.95
Return on Capital (%) -13.73
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 19.22
Total Assets 897.66
Total Liabilities 897.66
Total Equity 367.68
Share Outstanding 27598400
Price to Book Ratio 2.29
Return on Assets (%) 4.79
Return on Capital (%) 5.5
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.97
Total Assets 721.10
Total Liabilities 721.10
Total Equity 328.48
Share Outstanding 27598400
Price to Book Ratio 2.86
Return on Assets (%) 9.89
Return on Capital (%) 12.2
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 14.24
Total Assets 525.63
Total Liabilities 525.63
Total Equity 258.41
Share Outstanding 13799200
Price to Book Ratio 2.52
Return on Assets (%) 15.81
Return on Capital (%) 18.92
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 4.15
Total Assets 342.94
Total Liabilities 342.94
Total Equity 177.93
Share Outstanding 13799200
Price to Book Ratio 1.59
Return on Assets (%) 7.35
Return on Capital (%) 9.71
Particulars MAR 2024 (Values in Cr)
Net Income -103.86
Cash from Operations 105.08
Cash from Investing -11.24
Cash from Financing -96.59
Net change in Cash -15.54
Free Cash Flow 135.36
Particulars MAR 2023 (Values in Cr)
Net Income 58.21
Cash from Operations -10.65
Cash from Investing -93.42
Cash from Financing 131.36
Net change in Cash 15.74
Free Cash Flow 82.93
Particulars MAR 2022 (Values in Cr)
Net Income 89.68
Cash from Operations 10.31
Cash from Investing -74.79
Cash from Financing 61.84
Net change in Cash -12.26
Free Cash Flow 89.62
Particulars MAR 2021 (Values in Cr)
Net Income 118.81
Cash from Operations 79.20
Cash from Investing -108.93
Cash from Financing 75.45
Net change in Cash 10.08
Free Cash Flow 141.39
Particulars MAR 2020 (Values in Cr)
Net Income 36.06
Cash from Operations 29.69
Cash from Investing -27.56
Cash from Financing 3.28
Net change in Cash -3.70
Free Cash Flow 48.11
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.37 32.19 1.99 278.72 34.11 / 77.70
BLISS GVS PHARMA LTD 161.00 20.15 1.61 1697.67 105.05 / 184.95
CIPLA LTD 1488.15 23.36 3.85 120199.04 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 339.30 12.99 2.75 998.59 189.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 3259.30 63.18 28.29 55214.51 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.37 93.26 5.74 278.72 34.11 / 77.70
AMRUTAJAN HEALTH LTD 709.65 40.37 6.28 2051.64 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 9136.70 130.49 29.65 22841.75 6222.35 / 10653.05
BLISS GVS PHARMA LTD 161.00 24.62 1.60 1697.67 105.05 / 184.95

BAJAJ HEALTHCARE LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
484.60 3.85 redarrow
red-green-graph indicator
14 Bearish
2 Bullish
  • 5 Days 476.80
  • 26 Days 511.40
  • 10 Days 488.60
  • 50 Days 533.20
  • 12 Days 492.40
  • 100 Days 547.40
  • 20 Days 504.30
  • 200 Days 523.80
470.13 PIVOT

First Support

461.47

First Resistance

475.27

Second Support

456.33

Second Resistance

483.93

Third Support

447.67

Third Resistance

489.07

RSI

30.91

ADX

26.51

MACD

-18.97

Williams % R

-97.92

Commodity Channel Index (CCI)

-139.01

Date

2025-07-08

Week

116043.00

Same Day

48253.00

Month

64880.00

1 Year

1.35

3 Year

0.83

Over 1 Month

-12.22%

down

Over 1 Year

24.79%

down

Over 3 Months

-19.72%

down

Over 3 Years

15.38%

down

Over 6 Months

-19.09%

down

Over 5 Years

0.00%

down

BAJAJ HEALTHCARE LIMITED shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
37.24%
Promoter Holdings
59.18%
FII
1.04%
DII
2.52%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Sajankumar Rameshwarlal Bajaj 1.18707E7 (37.59%) Shareholding of Promoter and Promoter Group
Namrata Bajaj 1632207.0 (5.17%) Shareholding of Promoter and Promoter Group
Nihita Sajankumar Bajaj 1620360.0 (5.13%) Shareholding of Promoter and Promoter Group
Babita Sajankumar Bajaj 1504000.0 (4.76%) Shareholding of Promoter and Promoter Group
Anil Champalal Jain 1461775.0 (4.63%) Shareholding of Promoter and Promoter Group
Vanaja Sundar Iyer 700802.0 (2.22%) Public Shareholding
Weststone Management Consultancy Pvt Ltd 650888.0 (2.06%) Public Shareholding
Hdfc Mutual Fund - Hdfc Pharma And Healthcare Fund 518562.0 (1.64%) Public Shareholding
Padma Anil Jain 304000.0 (0.96%) Shareholding of Promoter and Promoter Group
Bajaj Health & Nutritions Private Limited 240000.0 (0.76%) Shareholding of Promoter and Promoter Group
Bansal Pharma Limited 60000.0 (0.19%) Shareholding of Promoter and Promoter Group
Dr. Ashish Garg 0.0 (0.0%) Public Shareholding
Mohit Poddar 0.0 (0.0%) Public Shareholding
Skr Bajaj Huf 0.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

BAJAJ HEALTHCARE LIMITED corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
22 Sep 2023 1.0 Final 23 Sep 2023 Equity shares
22 Sep 2022 1.5 Final 23 Sep 2022 Equity shares
28 Sep 2021 0.5 Final 29 Sep 2021 Equity shares
28 Sep 2021 0.5 Special 29 Sep 2021 Equity shares
01 Dec 2020 1.25 Interim 02 Dec 2020 Equity shares
01 Dec 2020 0.5 Special 02 Dec 2020 Equity shares
19 Sep 2018 1.0 Final 22 Sep 2018 Equity shares
Ex-Date Ex-Bonus Ratio
10 Apr 2019 09 Apr 2019 1:1
Ex-Date Old FV NEW FV Record Date
28 Sep 2021 10.0 5.0 29 Sep 2021
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
22 Sep 2023 1.0 Final 23 Sep 2023 Equity shares
22 Sep 2022 1.5 Final 23 Sep 2022 Equity shares
28 Sep 2021 0.5 Final 29 Sep 2021 Equity shares
28 Sep 2021 0.5 Special 29 Sep 2021 Equity shares
01 Dec 2020 1.25 Interim 02 Dec 2020 Equity shares
01 Dec 2020 0.5 Special 02 Dec 2020 Equity shares
19 Sep 2018 1.0 Final 22 Sep 2018 Equity shares
Ex-Date Ex-Bonus Ratio
10 Apr 2019 09 Apr 2019 1:1
Ex-Date Old FV NEW FV Record Date
28 Sep 2021 10.0 5.0 29 Sep 2021

BAJAJ HEALTHCARE LIMITED Share Price

Incorporated in 1993, Maharashtra-based Bajaj Healthcare Limited is one of India's large scale and vertically integrated pharmaceutical manufacturer for quality-conscious customers. The Company is engaged in the manufacturing of Active Pharmaceutical Ingredient (APIs), Intermediates, Finished Dosage Forms & Nutraceuticals.

The Company commenced its operations in 1993 with a single unit at Tarapur. It became a public company in 2005 and listed its shares in the Indian stock exchanges in 2016.

With Headquartered in Thane, Company has established 3 API plants in Gujarat and Maharashtra. It has 4 units for APIs/ intermediates and one unit for formulation, which are designed to meet the requirements of both advanced as well as emerging market opportunities. In 2008, the Company acquired Formulations plant at Manjusar, Vadodara and have converted it into WHO-GMP compliant facility. In 2013, it set up another API and Intermediate manufacturing plant at Panoli, Ankleshwar and acquired and set up an Intermediate Unit in Tarapur MIDC, near Mumbai in November, 2014.

In FY 2019-20, the Company acquired Intermediates manufacturing Unit at MIDC, Tarapur Maharashtra and also agreed to acquire Four Manufacturing facilities, comprising of three APIs manufacturing facilities, one Engineering Unit, at MIDC Tarapur, Maharashtra along with an Industrial Plot at Dahej, Gujarat.

The Company started commercial operations at Panoli Unit, in Bharuch from May 11, 2022. In 2021-22, it launched a Nutraceutical named Magnesium L-Threonate; commenced commercial production at Tarapur, for Nimesulide API, used for relief from pain and prevention of fever.

In 2023, the Company further launched 9 new molecules such as Glycine, Piperaquine phosphate, Amodiaquine hydrochloride, 4-7 DCQ, Hydroxy Novaldamine, 6-Chlorohexanone, Lafutidine, Zinc Ascorbate, Rivaroxaban in the Nutraceuticals, APIs, and Formulations segments.

In FY 2024, Company expanded the operations in the Alkaloids manufacturing business. It also established a new facility with the capacity to process approximately 250 metric tons of opium gum and around 2,500 metric tons of poppy straw.

Parent organization Indian Private
NSE symbol BAJAJHCARE
Founded 1993
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Bajaj Healthcare Ltd?

Answer Field

Bajaj Healthcare Ltd share price is for NSE ₹ 480.05 & for BSE ₹ 480.10 as on Jul 09 2025 01:30 PM.

What is the Market Cap of Bajaj Healthcare Ltd Share?

Answer Field

The market cap of Bajaj Healthcare Ltd for NSE ₹ 1,530.50 & for BSE ₹ 0.00 as on Jul 09 2025 01:30 PM.

What is the 52 Week High and Low of Bajaj Healthcare Ltd?

Answer Field

The 52 Week High and Low of Bajaj Healthcare Ltd for NSE is ₹ 745.00 and ₹ 330.90 and for BSE is ₹ 744.90 and ₹ 331.05.

What is 1 year return for Bajaj Healthcare Ltd?

Answer Field

The 1 year returns on the stock has been 24.79%.

What is the P/E Ratio of Bajaj Healthcare Ltd Share?

Answer Field

As on Jul 09 2025 01:30 PM the price-to-earnings (PE) ratio for Bajaj Healthcare Ltd share is 37.34.

What is the PB ratio of Bajaj Healthcare Ltd Share?

Answer Field

As on Jul 09 2025 01:30 PM, the price-to-book (PB) ratio for Bajaj Healthcare Ltd share is 147.59.

How to Buy Bajaj Healthcare Ltd Share?

Answer Field

You can trade in Bajaj Healthcare Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Bajaj Healthcare Ltd Share on Bajaj Broking App?

Answer Field

To buy Bajaj Healthcare Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Bajaj Healthcare Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|